SCHEMBL8539243

SCHEMBL8539243

CN(C(=O)Oc1ccc2c(ccn2N(C)c2ccncc2)c1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.54
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LIPE Q05469 3/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539620 0.86 SLC6A2 (0.65) SLC6A2RAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL8541743 0.81 SLC6A2 (0.56) SLC6A2RAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL8845727 0.81 KDM4C (0.46) RAB9ASMN1; SMN2NPC1KMT2AMEN1
SCHEMBL8539248 0.81 EPHX1 (0.50) SLC6A2RAB9ANPC1ACHE
SCHEMBL8845721 0.77 MAOA (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1ACHE
SCHEMBL9738895 0.77 SLC6A2 (0.45) SLC6A2SMN1; SMN2NPSR1LIPEALDH1A1
SCHEMBL8539582 0.77 SLC6A2 (0.57) SLC6A2RAB9ANPC1KMT2AMEN1
SCHEMBL8539631 0.77 SLC6A2 (0.65) SLC6A2SMN1; SMN2LIPELMNAL3MBTL1
SCHEMBL8845716 0.77 SLC6A2 (0.55) SLC6A2RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL8539588 0.76 SLC6A2 (0.50) SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5102891-A Useful for treating various memory dysfunctions such as alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-07 US claimed
EP-0468401-B1 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-09-16 EP disclosed
US-5102891-A Useful for treating various memory dysfunctions such as alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-07 US disclosed
EP-0468401-A2 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-01-29 EP disclosed